0001628280-21-013754.txt : 20210712 0001628280-21-013754.hdr.sgml : 20210712 20210712161615 ACCESSION NUMBER: 0001628280-21-013754 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210712 DATE AS OF CHANGE: 20210712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Levine James E. CENTRAL INDEX KEY: 0001463151 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35558 FILM NUMBER: 211085692 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: 8TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiff Oncology, Inc. CENTRAL INDEX KEY: 0001213037 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272004382 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-952-7570 MAIL ADDRESS: STREET 1: 11055 FLINTKOTE AVENUE CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Trovagene, Inc. DATE OF NAME CHANGE: 20130304 FORMER COMPANY: FORMER CONFORMED NAME: TrovaGene Inc. DATE OF NAME CHANGE: 20110830 FORMER COMPANY: FORMER CONFORMED NAME: XENOMICS INC DATE OF NAME CHANGE: 20040719 4 1 wf-form4_162612095825628.xml FORM 4 X0306 4 2021-07-12 0 0001213037 Cardiff Oncology, Inc. CRDF 0001463151 Levine James E. C/O CARDIFF ONCOLOGY, INC. 11055 FLITKOTE AVE SAN DIEGO CA 92121 0 1 0 0 Chief Financial Officer Common Stock 6.55 2021-07-12 4 A 0 390000 0 A 2031-07-12 Stock Options 390000.0 390000 D 97,500 vest on 7/12/2022. 8,125 vest monthly for 36 months beginning on 8/12/2022 through 7/12/2025. /s/ James Levine 2021-07-12